Tff Retained Earnings Total Equity from 2010 to 2024

TFFP Stock  USD 1.82  0.13  6.67%   
Tff Pharmaceuticals Retained Earnings Total Equity yearly trend continues to be relatively stable with very little volatility. Retained Earnings Total Equity is likely to drop to about -61.7 M. Retained Earnings Total Equity is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. View All Fundamentals
 
Retained Earnings Total Equity  
First Reported
2010-12-31
Previous Quarter
-58.8 M
Current Value
-61.7 M
Quarterly Volatility
13.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tff Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tff Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 29.2 K, Selling General Administrative of 6.8 M or Research Development of 9.9 M, as well as many indicators such as Price To Sales Ratio of 13.72, Dividend Yield of 0.0 or PTB Ratio of 1.38. Tff financial statements analysis is a perfect complement when working with Tff Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Tff Pharmaceuticals Correlation against competitors.
To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.

Latest Tff Pharmaceuticals' Retained Earnings Total Equity Growth Pattern

Below is the plot of the Retained Earnings Total Equity of Tff Pharmaceuticals over the last few years. It is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. Tff Pharmaceuticals' Retained Earnings Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tff Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Retained Earnings Total Equity10 Years Trend
Slightly volatile
   Retained Earnings Total Equity   
       Timeline  

Tff Retained Earnings Total Equity Regression Statistics

Arithmetic Mean(41,881,681)
Coefficient Of Variation(31.35)
Mean Deviation11,149,649
Median(34,279,648)
Standard Deviation13,130,718
Sample Variance172.4T
Range31M
R-Value(0.75)
Mean Square Error80.6T
R-Squared0.57
Significance0
Slope(2,208,975)
Total Sum of Squares2413.8T

Tff Retained Earnings Total Equity History

2024-61.7 M
2023-58.8 M
2021-65.3 M

About Tff Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Tff Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Tff Pharmaceuticals investors use historical funamental indicators, such as Tff Pharmaceuticals's Retained Earnings Total Equity, to determine how well the company is positioned to perform in the future. Although Tff Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Tff Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tff Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Tff Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Tff Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Retained Earnings Total Equity-58.8 M-61.7 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Tools for Tff Stock Analysis

When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.